Accolade raises $70M in Series E


What does Accolade do?

Accolade, is an on demand healthcare concierge for health plans, employers. This company is the leading provider of professional health assistant services. The company partners with large, innovative employers for improving and simplifying healthcare for emloyees and their families. The company creates and nurtures personal connections with employees via knowledgeable support of its health assistants. The company empowers employees and their families in getting more value from the healthcare system and their health benefits. Their trusted relationships and their wonderful service leads to better care outcomes, better results and greater satisfaction in more committed employees and long term money savings for employees.

How much Accolade was funded?

The company raised $71.1M in Series E on August 10, 2016 from Madrona Venture Group and Andreessen Horowitz.

Previous funding

$20M in Series A on February 1, 2007 from Accretive LLC

$4M on January 21, 2010

$16.94M in Series B on June 29, 2010 from Accretive LLC, Oak Hill Capital Partners and Comcast Ventures

$30M in Series D on December 22, 2013 from Carrick Capital Partners, Oak Hill Capital Partners and Comcast Ventures

$2.8M in undisclosed round on May 13, 2014

$22.5M in Series E on July 16, 2015 from McKesson Ventures and Independence Health Group.

What is next for Accolade?

Accolade plans to use the latest funding raised for expanding its tech platform, sales and marketing initiatives and research and development, as it reinvents the healthcare experience for millions of Americans.

More about Accolade

Accolade was founded by Michael Cline, John Rollins, Arun Gupta and Tom Spann. It has its headquarters in Plymouth Meeting, PA. The company is the best tool for helping companies simultaneously improving both the cost and the quality of healthcare. This is an on demand health concierge which is creating a better healthcare experience. It is driving satisfaction and world class engagement for customers.